कोशिश गोल्ड - मुक्त

Chronicle Pharmabiz - November 20, 2025

मैगज़्टर गोल्ड के साथ असीमित हो जाओ

पढ़ना Chronicle Pharmabiz केवल एक सदस्यता के साथ 10,000+ अन्य पत्रिकाएँ और समाचार पत्र

कैटलॉग देखें

1 महीना

$14.99

1 वर्ष $149.99

$149.99

$12/month

(OR)

केवल Chronicle Pharmabiz की सदस्यता लें

उपहार Chronicle Pharmabiz

किसी भी समय रद्द करें.

(कोई प्रतिबद्धता नहीं) ⓘ

यदि आप सदस्यता से खुश नहीं हैं, तो आप पूर्ण धनवापसी के लिए सदस्यता आरंभ तिथि से 7 दिनों के भीतर हमें help@magzter.com पर ईमेल कर सकते हैं। कोई प्रश्न नहीं पूछा जाएगा - वादा! (नोट: एकल अंक खरीद के लिए लागू नहीं)

डिजिटल सदस्यता

त्वरित पहुँच ⓘ

मैगज़टर वेबसाइट, आईओएस, एंड्रॉइड और अमेज़ॅन ऐप पर तुरंत पढ़ना शुरू करने के लिए अभी सदस्यता लें।

सत्यापित सुरक्षित

भुगतान ⓘ

मैगज़्टर एक सत्यापित स्ट्राइप व्यापारी है।

इस अंक में

Volume 25, Issue No. 52 - November 20, 2025 Chronicle Pharmabiz

Panel recommends DoP to study on difference between PTS, MRP

THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DOP) to conduct a study on the significant difference between the Price to Stockist (PTS) and Maximum Retail Price (MRP) printed on the medicine, and the reasons.

2 mins

Botswana becomes 18th country to recognize IP

BOTSWANA has become the 18th country to officially sign a memorandum of understanding (MoU) to recognize Indian Pharmacopoeia (IP) as a book of standards for medicines. This recognition of IP in Botswana will remove double regulation, duplication in testing and post importation checks. This will further facilitate easier access to quality and affordable Indian medicines in Botswana and hence boost Indian pharma exports.

1 mins

ICMR invites EoIs for data contribution for pregnancy cohort studies

IN order to understand hypothyroidism during pregnancy among Indian women, the Indian Council of Medical Research (ICMR) has invited Expression of Interests (Eols) from researchers and institutions to contribute data from ongoing or completed pregnancy cohort studies or randomized controlled trials (RCTs).

2 mins

Glasgow Univ's bioengineered bone marrow used in leukaemia research

UNIVERSITY of Glasgow rely used the first bioengineered bone marrow model to carry out vital cancer research, offering new insights into potential therapies for the disease.

2 mins

ICMR lists important pathogens causing critical infections

THE Division of Communicable Diseases of Indian Council of Medical Research (ICMR) has listed important pathogens causing critical infectious syndromes in India to guide patient management, public health policies, and biomedical research and development (R&D).

2 mins

Alembic gets US FDA final approval for diltiazem tablets.

ALEMBIC Pharmaceuticals A Limited (Alembic), a verti cally integrated research and development pharmaceutical company, announced that it has received final approval from the US FDA for its Abbreviated New Drug Application (ANDA) diltiazem hydrochloride tablets USP, 30 mg, 60 mg, 90 mg, and 120 mg.

1 mins

Lupin launches risperidone with 180-day CGT exclusivity

GLOBAL pharma major Lupin the launch of risperidone for extended-release injectable suspension, 25 mg per vial, 37.5 mg per vial, and 50 mg per vial, single-dose vials, with 180-day CGT exclusivity in the US.

1 mins

GLS gets US FDA nod for Hyderabad unit

RANULES India's wholly owned subsidiary, Granules Life Sciences (GLS), located in Hyderabad has received US Food and Drug Administration (FDA) approval for a product that was the subject of a Pre- Approval Inspection (PAI) conducted between July 28 and August 1, 2025.

1 mins

Novo Nordisk's Wegovy price slash a game-changer for obesity: BDCDA

THE Bangalore District Chemists and Druggists welcomed Novo Nordisk's decision to reduce the price of its anti-obesity medication, Wegovy, by up to 37%.

2 mins

India sets global benchmark in rabies prophylaxis through RmAbs

NDIA leads the world in advanced rabies prophylaxis by manufacturing Rabies Monoclonal Antibodies (RmAbs), including WHO-collaborated Cocktail RmAbs.

1 mins

'Indian pharma's fundamentals signal shift towards science-driven models'

THE Indian pharmaceutical industry's defining trend currently is the shift from volume-led growth to valueand innovation-led expansion.

1 mins

Karnataka pharma in compliance mode for revised Schedule M

THE Karnataka pharmaceutical industry has worked diligently to comply with the revised Schedule M of the Drugs Rules, which governs the manufacturing and quality control of drugs.

2 mins

Aurobindo Pharma net profit up 3.8% in Q2

AUROBINDO Pharma, a second largest Indian pharma Company with revenues of Rs. 31,700 crore plus, has posted single digit growth in revenues as well as profits during the second quarter ended September 2025. Its consolidated revenue increased by 6.3 per cent to Rs.8,286 crore from Rs. 7,796 crore in the corresponding period of ast year.

1 mins

Alkem Lab reports 17% revenue growth in Q2 FY26

ALKEM Laboratories Ltd. to report and consolidated financial results for the second quarter ended September 30, 2025. The board of directors took record of these results at its meeting held in Mumbai today.

1 mins

KSMSC to procure ₹800 cr of medicines with strict quality control

THE Karnataka State Medical Supplies Corporation (KSMSC) is now all set to procure tenders for pharmaceutical supplies, potentially worth Rs. 800 crore, with a focus on stringent quality control measures. The corporation had earlier invited tenders for 100 drugs worth Rs. 485 crore. All this would include multiple checks and testing for each batch of drugs to ensure the highest standards are maintained.

2 mins

Rejection of trial waiver for Hetero's lenacapavir will impact India, LMICS: TWN

THE decision of the Subject Expert Committee (SEC) under the Central Drugs Standard Control Organisation (CDSCO) to reject Hetero Lab's request for waiver of two studies for the manufacturing and marketing of generic lenacapavir 300 mg tablet will impact the accessibility of the generic equivalent of Gilead's HIV drug in India and the low-and-middle income countries (LMICs), according to an independent nonprofit international research and advocacy organisation.

3 mins

PCI directs Councils to submit pharmacists' data by Nov 30

THE Pharmacy Council of India (PCI) has directed all the State Pharmacy Councils to submit the data of registered pharmacists in their States in a stipulated format on immediate basis by November 30, 2025, in order to facilitate National Health Authority (NHA) to create a consolidated data on pharmacists in the country under the Health Professional Registry (HPR).

2 mins

A Scheme to Unleash Innovation Potential

THE Department of Pharmaceuticals (DoP) has recently notified the amendments to the Rs. 5,000 crore Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme which will build an advanced R&D infrastructure across the country.

2 mins

Ghaziabad-based IPC inks MoU with TNPC

THE Ghaziabad-based Indian Pharmacopoeia Commission (IPC) has signed a Memorandum of Understanding (MoU) with the Tamil Nadu Pharmacy Council (TNPC) to promote safe and rational use of medicines through joint initiatives in pharmacovigilance, patient safety, and professional awareness among pharmacists.

1 mins

CDSCO alerts on toxic syrup; Haryana to expand quality vigil

A critical public health alert has been issued following the detection of a toxic impurity, diethylene glycol (DEG), in a batch of cough syrup, triggering immediate and stringent regulatory action across India, particularly in Haryana.

2 mins

IP gets recognition as book of standards in 17 countries

THE Indian Pharmacopoeia (IP) as a book of standards for medicines has been recognized by 17 countries till date. This will ensure quality medicines being manufactured and/or imported in the respective foreign countries and hence boost exports.

2 mins

APPC election hit by allegations

As preparations for the Andhra Pradesh Pharmacy Council (APPC) elections 2025 are underway, various panels are busy finalizing their candidates, setting the stage for a charged contest over the future governance of the state's pharmacy profession.

1 mins

सभी कहानियाँ पढ़ें Chronicle Pharmabiz

Chronicle Pharmabiz Description:

प्रकाशक: Saffron-Media-Pvt-Ltd

वर्ग: Health

भाषा: English

आवृत्ति: Weekly

Launched on 21 December 2000, Chronicle Pharmabiz is the No. 1 Pharma news weekly in the South Asian markets; with a target readership that includes 100% coverage of top and middle management pharma professionals across the region.